Grifols S A : December 16, 2020Grifols creates a Sustainability Committee to strengthen its long-term sustainable growth model

Grifols creates a Sustainability Committee to strengthen its long-term sustainable growth model

• Grifols bolsters its corporate governance structure, reinforcing its position as a responsible and transparent company committed to its stakeholders
• The Sustainability Committee, delegated by Grifols' Board of Directors, will establish the core principles and commitments regarding environmental and social responsibility in the company's business model and supervise the integration of financial and non-financial information on the ESG (environmental, social and corporate governance)
• Grifols' Board of Directors also approved a new Sustainability Policy and a new Policy on Communication and Contacts with Shareholders, Institutional Investors and Proxy Advisors

Barcelona, December 16, 2020.- The Board of Directors of Grifols (MCE: GRF, MCE: GRF.P,

NASDAQ: GRFS) strengthens its corporate governance structure with the creation of a new sustainability committee, aimed at enhancing the company's role as a responsible and transparent organization committed to its stakeholders through the continuous improvement of its economic, social, environmental and corporate governance performance. This newly formed commission joins the Appointments and Remuneration Committee and the Audit Committee.

The Sustainability Committee will establish the core principles and commitments on environmental and social responsibility in the company's business model and supervise the integration of financial and non-financial information on the ESG (environmental, social and corporate governance).

This newly formed committee reflects Grifols' commitment to long-term sustainability and the Sustainable Development Goals (SDGs) that are integrated into the firm's business model to amplify the positive impact and value generated by its operations. Since its origins more than 100 years ago, Grifols has embraced a business model grounded on solid corporate governance and guided by integrity, ethics, safety, quality and innovation as core values, aligned with its mission of enhancing the health and well-being of people worldwide.

The Sustainability Committee is formed by three directors: Thomas Glanzmann, as President, Íñigo Sánchez-Asiaín Mardones and Enriqueta Felip Font. Nuria Núria Martín Barnés will be the Secretary of this Committee.

Page 1 of 4

For Víctor Grífols Roura, Chairman of Grifols' Board of Directors: "The creation of a Sustainability Committee is another important step forward which emphasizes that environmental, social and corporate governance factors have always been a priority for us. Our desire and intention is to make a positive impact, which is why sustainability matters play such a critical role in our executive agenda. Our efforts against climate change; promote diversity, inclusion and work-lifebalance; ensure the health and safety of our donors, patients and employees; and foster innovation and science as drivers of social progress within society are part of our culture and values."

To this end, Grifols' Board of Directors also approved a new Sustainability Policy to reinforce these fundamental principles and commitments in relation to environmental and social responsibility, serving as a basis for their integration into the Grifols' business model; and a new Policy on Communication and Contacts with Shareholders, Institutional Investors and Proxy Advisors, which outlines principles of transparency, truthfulness, equality and immediacy in the disclosure of all financial and non-financial information.

Amid the current context and in light of the uncertainties arising from the COVID-19 pandemic, Grifols continues to respond in a decisive, efficient and agile way to bolster its business model and meet the evolving needs and demands during these unprecedented times in terms of sustainability and ethics and to promote its commitment to all its stakeholders.

Presence on sustainability indices

In 2020, Grifols was recognized as one of the most sustainable companies in the world by a diversity of indices and rating agencies. In November 2020, the company was included in the Dow Jones Sustainability Index (DJSI) Europe - an international reference in assessing the sustainability performance of publicly traded firms - for the first time.

The company was also included in the Euronext Vigeo Europe 120 and Euronext Vigeo Eurozone 120 indices based on the assessment by Vigeo Eiris, the prestigious rating agency that evaluates the performance of Europe's most sustainable companies.

In addition, Grifols improved its score on the Carbon Disclosure Project (CDP), the world's leading environmental information platform which annually assesses corporate strategies and performance in relation to climate change. In 2020, the company attained an "A-" management rating.

Furthermore, Grifols has formed part of the FTSE4Good Global, FTSE4Good Europe and FTSE4Good Ibex indices since 2018.

Page 2 of 4

Investor contact:

Investor [e-mail] [e-mail] number: [phone]

Media contacts:

Raquel [e-mail]

Borja Gó[e-mail]

Duomo Comunicación - Grifols PR office

Tel. [phone]

About Grifols

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people around the world. Its four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative solutions and services that are sold in more than 100 countries.

Pioneers in the plasma industry, Grifols operates a growing network of donation centers worldwide. It transforms collected plasma into essential medicines to treat chronic, rare and, at times, life-threatening conditions. As a recognized leader in transfusion medicine, Grifols also offers a comprehensive portfolio of solutions designed to enhance safety from donation to transfusion. In addition, the company supplies tools, information and services that enable hospitals, pharmacies and healthcare professionals to efficiently deliver expert medical care.

Grifols, with more than 24,000 employees in 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership.

In 2019, Grifols' economic impact in its core countries of operation was EUR 8.5 billion. The company also generated 148,000 jobs, including indirect and induced.

The company's class A shares are listed on the Spanish Stock Exchange, where they are part of the Ibex-35 (MCE:GRF). Grifols non-voting class B shares are listed on the Mercado Continuo (MCE:GRF.P) and on the U.S. NASDAQ through ADRs (NASDAQ:GRFS).

For more information, please visit www.grifols.com

Page 3 of 4

LEGAL DISCLAIMER

The facts and figures contained in this report that do not refer to historical data are "future projections and assumptions". Words and expressions such as "believe", "hope", "anticipate", "predict", "expect", "intend", "should", "will seek to achieve", "it is estimated", "future" and similar expressions, in so far as they relate to the Grifols group, are used to identify future projections and assumptions. These expressions reflect the assumptions, hypotheses, expectations and predictions of the management team at the time of writing this report, and these are subject to a number of factors that mean that the actual results may be materially different. The future results of the Grifols group could be affected by events relating to its own activities, such as a shortage of supplies of raw materials for the manufacture of its products, the appearance of competitor products on the market, or changes to the regulatory framework of the markets in which it operates, among others. At the date of compiling this report, the Grifols group has adopted the necessary measures to mitigate the potential impact of these events. Grifols, S.A. does not accept any obligation to publicly report, revise or update future projections or assumptions to adapt them to events or circumstances subsequent to the date of writing this report, except where expressly required by the applicable legislation. This document does not constitute an offer or invitation to buy or subscribe shares in accordance with the provisions of the following Spanish legislation: Royal Legislative Decree 4/2015, of 23 October, approving recast text of Securities Market Law; Royal Decree Law 5/2005, of 11 March and/or Royal Decree 1310/2005, of 4 November, and any regulations developing this legislation. In addition, this document does not constitute an offer of purchase, sale or exchange, or a request for an offer of purchase, sale or exchange of securities, or a request for any vote or approval in any other jurisdiction. The information included in this document has not been verified nor reviewed by the external auditors of the Grifols group.

Page 4 of 4